EMPREENDIMENTOS PAGUE MENOS S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.43 BRL | -5.08% |
|
-2.80% | -38.64% |
| Sales 2024 * | 12.29B 2.39B | Sales 2025 * | 13.17B 2.56B | Capitalization | 1.44B 279M |
|---|---|---|---|---|---|
| Net income 2024 * | 24M 4.67M | Net income 2025 * | 98M 19.06M | EV / Sales 2024 * | 0.23 x |
| Net Debt 2024 * | 1.38B 269M | Net Debt 2025 * | 1.02B 199M | EV / Sales 2025 * | 0.19 x |
| P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
10.8
x | Employees | 25,819 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.86% |
More Fundamentals
* Assessed data
More news
Latest transcript on Empreendimentos Pague Menos S.A.
More press releases
| 1 day | -5.08% | ||
| 1 week | -2.80% | ||
| Current month | -3.95% | ||
| 1 month | -4.33% | ||
| 3 months | -14.74% | ||
| 6 months | -30.37% | ||
| Current year | -38.64% |
1 week
2.43
2.62
1 month
2.432.66
Current year
2.403.96
1 year
2.404.75
3 years
2.4013.75
5 years
2.4013.75
10 years
2.4013.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 47 | 15-12-31 | |
Gianni Dias Gill
COO | Chief Operating Officer | - | 21-06-30 |
| Chief Tech/Sci/R&D Officer | - | 01-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 46 | - | |
| Director/Board Member | - | 81-12-31 | |
| Director/Board Member | 52 | 97-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +4.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 2.43 | -5.08% | 164 500 |
| 24-05-22 | 2.47 | -3.52% | 608,000 |
| 24-05-21 | 2.56 | -0.78% | 792,500 |
| 24-05-20 | 2.58 | +1.57% | 994,600 |
| 24-05-17 | 2.54 | +1.60% | 420,200 |
Delayed Quote Sao Paulo, May 23, 2024 at 10:09 am EDT
More quotes
Empreendimentos Pague Menos SA is a Brazil-based company primarily engaged in the drug retail sector. Through a drugstore chain, the Company sells medicines, perfumes, personal care and household products, cosmetics, as well as grocery goods, among others. Additionally, It offers a range of financial services, such as bill collection and credit card issuing. The Company also operates a call center that provides information related to drugs usage.
Sector
Drug Retailers
Calendar
2024-08-04
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
2.47
BRL
Average target price
3.79
BRL
Spread / Average Target
+53.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.64% | 279M | |
| -38.06% | 14.21B | |
| -29.16% | 11.58B | |
| -27.59% | 6.51B | |
| +13.06% | 6.32B | |
| -8.13% | 6.15B | |
| +71.17% | 4.98B | |
| -6.68% | 3.97B | |
| -12.41% | 3.43B | |
| -9.81% | 2.96B |
- Stock Market
- Equities
- PGMN3 Stock
